registration
Schientific Committee
Chairs and Faculty
Program
Accreditation
Abstracts
Young Investigators
Accommodations
Support or Exhibit
Contact Us
Home Page

3rd Global Symposium on IGRAs - Syllabus

Friday, January 13, 2012
8:25

Welcome and Opening Remarks, Antonino Catanzaro, MD and Charles L. Daley, MD

8:30 The New Understanding of the Dynamics of TB Infection, Clifton E. Barry, III, PhD
9:10

What IGRAs Have Allowed Us to Understand About TB, David Lewinsohn, MD, PhD

Download the audio from this presentation

9:50

Commentary, Michael D. Iseman, MD

Download the audio from this presentation

10:40

What Does the Experience with Immune Modifiers Tell Us About the Mechanism and Risk of Progression to TB Disease, Robert S. Wallis, MD, FIDSA

Download the audio from this presentation

11:20

Commentary, Jerold J. Ellner, MD

Download the audio from this presentation

1:30

Do IGRAs Identify Persons Who Are Likely Not to Progress to Active TB, Albert Nienhaus, MD, PhD

Download the audio from this presentation

2:10

How Well Do IGRAs Perform the Identification of Persons Who Are Likely to Progress to Active TB, Pranab Haldar, MD, MRCP

Download the audio from this presentation

3:10

Predictive Value of IGRAs for Progression to Active Tuberculosis in HIV 1 Infected Women, S. Jonnalagadda

Download the audio from this presentation

3:25

Predictive Value of IGRAs for Progression to Active Tuberculosis in TB Contacts in Singapore, C. Chee

Download the audio from this presentation

3:40

Predictive Value of IGRAs for Progression to Active Tuberculosis in Children: Results of a Longitudinal Study in Germany Using IGRAs, Stefanie Castell, MD, MSc

Download the audio from this presentation

4:00

Commentary, Ibrahim Abubakar, MD, PhD

Download the audio from this presentation

Saturday, January 14, 2012
8:30

Use of IGRAs In the Face of Other Co Morbidities, Luca Richeldi, MD, PhD

Download the audio from this presentation

9:10

Repeated Quantiferon TB Gold in Tube Tests in Routine Clinical Practice: AFive Years Experience, S. Cerr

Download the audio from this presentation

9:25

Use of IGRAs in the Face of HIV Immune Modifiers, Pernille Ravn, MD, PhD

Download the audio from this presentation

10:05

Screening HIV Infected Patients with IGRAs for LTBI, K. Sakashita

Download the audio from this presentation

10:40

Serial Testing with IGRAs in High Risk Populations, R. Garfein

Download the audio from this presentation

10:55

Use of IGRAs in the Face of Immune Modifiers, Stephan Gadola, MD, PhD

Download the audio from this presentation

11:35

What is the Effect on the IGRA Response By Prednisolone, Tobacco or Inflammatory Bowel Disease? A. Werlinrud

Download the audio from this presentation

11:45

Commentary, Neil Schluger, MD

Download the audio from this presentation

1:30

IGRA Testing of HCW, Charles L. Daley, MD

Download the audio from this presentation

2:10

Active TB in Portuguese HCW, a Descriptive Study, José Castela Torres da Costa

Download the audio from this presentation

2:25

IGRAs and Missed Opportunities to Prevent Active Tuberculosis in Healthcare Workers with Positive Tuberculin Skin Tests Attributed to Bacille Calmette Guerin (BCG) Vaccination, J. Katsolis

Download the audio from this presentation

2:40

Cost Effectivness and Operating Characteristics of Using Igras in US Healthcare Workers, W. Thanassi

Download the audio from this presentation

2:55

Commentary, Renee Ridzon, MD

Download the audio from this presentation

3:45

Interpretation of IGRA Results, Edward A. Graviss, PhD, MPH

Download the audio from this presentation

4:25

Within Subject Variability of the Quantiferon TB Gold in Tube Assay in a Large Cohort of Low Risk Subjects, J. Metcalfe

Download the audio from this presentation

4:40

A Data Based Algorithm for the Clinical Management of Persons with Fluctuations in Serial IGRA Tests to Detect LTBI, D. Marder

Download the audio from this presentation

5:00

Commentary, Matthew J. Binnicker, PhD

Download the audio from this presentation

Sunday, January 15, 2012
8:30

Dried Plasma Spots in the Diagnosis of TB Infection: IP-10 Release Assay on Filter Paper, M. Ruhwald

Download the audio from this presentation

8:45

Pilot Study of Latent Tuberculosis Infection with an Enhanced Elispot Interferon Gamma Release Assay, P. Escalant

Download the audio from this presentation

9:00

Cost Effectiveness of IGRAs Versus Chest X Ray for Tuberculosis Screening, A. Kowada

Download the audio from this presentation

9:15

Prevalence of LBTI in the General Public in Mazovia and HCW in Poland Using Igras, U. Demkow

Download the audio from this presentation

9:30

Screening of HCW and Immigrants with IGRA and TST in Mexico L. Todd, L. Machado, A. Diaz

Download the audio from this presentation

9:45

Commentary, Toru Mori, MD, PhD

Download the audio from this presentation

10:30

The Use of IGRAs in Children: View From the Laboratory, Beate Hyme, FRCPCH, MD, PhD

Download the audio from this presentation

11:30

The Use of IGRAs in Children: View from the Clinic, Jeffrey Starke, MD

Download the audio from this presentation

1:30

What Would it Take to Eliminate Tuberculosis by 2050, Laith J. Abu-Raddad, Phd

Download the audio from this presentation

2:00

Eliminating TB by 2050, Mario Raviglione, MD

Download the audio from this presentation

2:40

Global Applications, Richard O'Brien, MD

2:50

Predictive Value of IGRAs for Progression to Active TB in Children: Results of a longitudinal Study in Germany Using IGRAs, Stefanie Castell, MD, MSc and Roland Diel

Download the audio from this presentation

3:40

How Does the Concept of Diagnosing and Treating LTBI Fit Into TB Control in Low, Medium and High Burdon Countries, Edward Nardell, MD

Download the audio from this presentation


ucsd

UC San Diego School of Medicine
Continuing Medical Education
2251 San Diego Ave., A-160
San Diego, CA 92110

Phone: (619) 543-7602 • Toll-Free: (888) 229-OCME (6263) • Fax: (619) 543-7610
E-mail: ocme@ucsd.edu • Website: cme.ucsd.edu


For technical comments or questions, contact the webmaster.
Copyright 2011, University of California, San Diego. All rights reserved.